|Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas|
CJ Wikstrand, LP Hale, SK Batra, ML Hill, PA Humphrey, SN Kurpad, ...
Cancer research 55 (14), 3140-3148, 1995
|Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.|
PA Humphrey, AJ Wong, B Vogelstein, MR Zalutsky, GN Fuller, GE Archer, ...
Proceedings of the National Academy of Sciences 87 (11), 4207-4211, 1990
|Pinhole collimation for ultra-high-resolution, small-field-of-view SPECT|
RJ Jaszczak, J Li, H Wang, MR Zalutsky, RE Coleman
Physics in Medicine & Biology 39 (3), 425, 1994
|Clinical experience with α-particle–emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6|
MR Zalutsky, DA Reardon, G Akabani, RE Coleman, AH Friedman, ...
Journal of Nuclear Medicine 49 (1), 30-38, 2008
|Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia|
DE Meyer, GA Kong, MW Dewhirst, MR Zalutsky, A Chilkoti
Cancer research 61 (4), 1548-1554, 2001
|Phase II Trial of Murine 131I-Labeled Antitenascin Monoclonal Antibody 81C6 Administered Into Surgically Created Resection Cavities of Patients With Newly …|
DA Reardon, G Akabani, R Edward Coleman, AH Friedman, HS Friedman, ...
Journal of Clinical Oncology 20 (5), 1389-1397, 2002
|Radiolocalization of human mammary tumors in athymic mice by a monoclonal antibody|
D Colcher, M Zalutsky, W Kaplan, D Kufe, F Austin, J Schlom
Cancer research 43 (2), 736-742, 1983
|Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-α and a mutated form of the …|
JH Sampson, G Akabani, GE Archer, DD Bigner, MS Berger, AH Friedman, ...
Journal of neuro-oncology 65 (1), 27-35, 2003
|The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target|
CJ Wikstrand, CJ Reist, GE Archer, MR Zalutsky, DD Bigner
Journal of neurovirology 4 (2), 148-158, 1998
|Astatine-211-labeled radiotherapeutics an emerging approach to targeted alpha-particle radiotherapy|
MR Zalutsky, G Vaidyanathan
Current pharmaceutical design 6 (14), 1433-1455, 2000
|A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine|
MR Zalutsky, AS Narula
International Journal of Radiation Applications and Instrumentation. Part A …, 1987
|Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.|
DD Bigner, MT Brown, AH Friedman, RE Coleman, G Akabani, ...
Journal of clinical oncology 16 (6), 2202-2212, 1998
|A plasmonic gold nanostar theranostic probe for in vivo tumor imaging and photothermal therapy|
Y Liu, JR Ashton, EJ Moding, H Yuan, JK Register, AM Fales, J Choi, ...
Theranostics 5 (9), 946, 2015
|A thermally responsive biopolymer for intra-articular drug delivery|
H Betre, W Liu, MR Zalutsky, A Chilkoti, VB Kraus, LA Setton
Journal of controlled release 115 (2), 175-182, 2006
|Salvage radioimmunotherapy with murine iodine-131–labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: Phase …|
DA Reardon, G Akabani, RE Coleman, AH Friedman, HS Friedman, ...
Journal of clinical oncology 24 (1), 115-122, 2006
|Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors|
JH Sampson, G Akabani, GE Archer, MS Berger, RE Coleman, ...
Neuro-oncology 10 (3), 320-329, 2008
|In situ growth of a stoichiometric PEG-like conjugate at a protein's N-terminus with significantly improved pharmacokinetics|
W Gao, W Liu, JA Mackay, MR Zalutsky, EJ Toone, A Chilkoti
Proceedings of the National Academy of Sciences 106 (36), 15231-15236, 2009
|Radiation-induced biologic bystander effect elicited in vitro by targeted radiopharmaceuticals labeled with α-, β-, and Auger electron–emitting radionuclides|
M Boyd, SC Ross, J Dorrens, NE Fullerton, KW Tan, MR Zalutsky, ...
Journal of nuclear medicine 47 (6), 1007-1015, 2006
|Pharmacokinetics and tumor localization of 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies|
MR Zalutsky, RP Moseley, HB Coakham, RE Coleman, DD Bigner
Cancer research 49 (10), 2807-2813, 1989
|Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F] fluorobenzoate|
G Vaidyanathan, MR Zalutsky
International journal of radiation applications and instrumentation. Part B …, 1992